PLEASANTON, Calif., Aug. 26, 2011 /PRNewswire/ — QuantaLife,
Inc., a pioneer in the area of digital PCR, is embarking on a
seven-city tour to give scientists the opportunity to evaluate the
capabilities of digital PCR and see the QuantaLife Droplet Digital
PCR (ddPCR™) System in action. The tour will start on Monday,
September 12 in Boston and finish up in San Francisco on Friday,
September 23.
The QuantaLife ddPCR System claims to be the world’s most
precise quantitative PCR system. It introduces the next generation
of PCR by providing absolute quantification of targeted nucleic
acid molecules, a capability that could play a significant role in
the development of companion diagnostics and the emergence of
personalized medicine – a role that has long been held by
real-time PCR.
The Droplet Digital PCR Road Show will take place at the
following cities from September 12 through September 23:
- Boston, MA: Monday, September 12
- Potomac, MD: Tuesday, September 13
- New York, NY: Friday, September 16
- Chicago, IL: Monday, September 19
- Seattle, WA: Tuesday, September 20
- San Diego, CA: Wednesday, September 21
- San Francisco, CA: Friday, September 23
The featured speaker is Dr. Jason H. Bielas of the Fred
Hutchinson Cancer Research Center who will present his results from
the use of the ddPCR system in the study of mutation detection in
clinical samples. Breakout sessions will also be held on the use of
ddPCR for sensitive detection of rare mutants, measurement of copy
number, and gene expression. A ddPCR system will be available
for demonstration.
There is no charge for attendees. Details and registration
information are available at www.QuantaLife.com or by
calling (650) 823-6366. Space is limited, and early registration is
strongly encouraged.
The QuantaLife Droplet Digital PCR sys
‘/>”/>
SOURCE
